SlideShare a Scribd company logo
 The chemical name of Histamine
is “2-(4H-imidazol-5-yl) ethanamine (Histamine)”.
Histamine synthesized in cytoplasmic granules of a its storage cells, mast cells & basophils.
It is formed from naturally occurring amino acids, S-Histidine, via the catalysis of pyridoxal phosphate-
dependent enzymes histidine decarboxylase/ aromatic decarboxylase.
Histamine is a chiral molecule.
HISTAMINE
❑. Question:01 Write the chemical name & structure of Histamine?
❑. Question:02 Explain biosynthesis of Histamine?
NH2
N
HN
H
H
Histamine
HDC
COOH
HN N HN N
H
NH2
NH2
H
H
S-Histidine Histidine
Histidine
Decarboxylase
RAHUL PAL
5TH SEM
B. PHARAM
Drugs the block the action of histamine of H1, H2, H4 & H4 receptors.
The development of Antihistamines Began by the discovery of “Piperoxam”.
A. Drugs that inhibits the histamine release.
B. Drugs that inhibits the action of released histamine.
❑ H1 Antagonists (I, II, III generation Antagonists)
❑ H2 Antagonists.
❑ H3 Antagonists.
C. Drugs having dual action.
H1 Antagonists (1st
Generation)
The amine is substituted with the small alkyl group.
Classification: The commonly used antihistamines may be classified on the basis of their chemical
structures:
. Amino Alkyl Ethers: Diphenhydramine, Doxylamine, Clemastine, medrylamine,
Carbinoxmine, Bromodiphenhydramine.
. Ethylenediamine: Tripelenamine, pyrilamine, methapyrilene, thonzalamine, Zolamine.
. Propyl Amine Derivatives: Saturated drugs: pheniramine, chlorpheramine,
Unsaturated Drugs: Pyrrobutamine, triprolidine.
. Phenothiazine Derivatives. Promethazine, Trimeprazine.
. Piperazine Derivative. Cyclazine, chlorcyclines, meclizine.
H1 Antagonists (2nd
Generation)
Laratidine, Estemizole.
H1 Antagonists (3rd
Generation)
Acrivestine.
H2 Antagonists
Cemetidine, famotidine, ranitidine, nizatidine.
H3 Antagonist
Omeprazole, Lansoprazole, Rabeprazole, Pantoprazole.
❑. Question: 03 Classification of Antihistamines?
Histamines receptors are belonging to the family of G-Protein Coupled receptors.
These subtypes of histamine receptors:
A. H1.
B. H2.
C. H3.
D. H4.
Receptors H1 H2 H3 H4
Locations Brain, GIT, CVS,
Lymphocytes.
Myocardial cells,
parietal cells.
CNS, Myentric
plexus, gastric
Mucosa.
Spleen, thymus,
T-cells,
eosinophils.
❑. Question: 04 Name the different type of Histamine receptors & their
Distribution?
01. Amino Alkyl Ether: Diphenhydramine, Bromodiphenhydramine, Dimenhydrinate, Doxylamine
succinate, Diphenylpyraline.
02. Ethylenediamine: Mepyramine, Tripelennamine, Thonzylamine, Zolamine.
03. Thiophene Derivatives: Methapyrilene, Methaphenilene, Thenyldiamine, Chlorothen Citrate.
04. Cyclic Basic Chain Analogues:
A. Imidazoline: Antazoline.
B. Piperazine: Cyclizine, Chlorcyclizine, Meclizine, Buclizine.
C. Piperidine: Thenalidine Tartarate.
05. Phenothiazine: Promethazine, Promethazine Teolclate, Trimeprazine, Methdilazine.
06. Second-Generation Non-Sedating Antihistamines: Terfenadine, Astemizole, Loratadine,
Acrivastine.
07. Miscellaneous Agents: Phenindamine, Triprolidine, Chlorpheniramine, Cyproheptadine.
Sedative antihistamines:
N-Dimethylthenamine.HCl & 1-Methyl Piperidine.
Non-Sedative Antihistamine:
Fexofenadine, Citrizine Levocetrazine, loratadine, Desloratadine, Acrivastine.
Ar is Aryl: Phenyl, substituted phenyl, heteroaryl groups such as 2-pyridyl.
Ar1: Second aryl or aryl methyl group.
(CH2) n: Represents a carbon chain, usually ethyl.
NRR1 = Basic, terminal amine functional group.
X = Connecting atom of 0, C & N.
❑. Question:01 Give the classification of H1 Antagonists?
❑. Question:02 Explain SAR of Amino Alkyl Ethers?
H1 ANTAGONISTS
R R1
Mepyramine, Tripelennamine, Thonzylamine, Zolamine.
❑. Question:03 Give Chemical Structure of Amino Alkyl Ethers?
❑. Question:04 Give Chemical Structure of Ethylenediamine Derivatives?
Mepyramine Tripelennamine Thonzylamine
Zolamine
ANS: Structure Activity Relationship:
➢ Ethylenediamine derivatives are characterized by “Nitrogen” connecting
atom.
➢ Phenbenzamine was first clinically useful member.
➢ Replacement of phenyl moiety of Phenbezamine with a 2-pyridyl system
yielded “tripelennamine”.
➢ Replacements of benzyl group of tripelennamine with a 2-thienulmethyl
group provided methapyrilene.
➢ Replacement of tripelennamine with 2pyridyl group with a pyrimidinyl
moiety yields thonzylamine.
➢ The anticholinergic & antiemetics action of these compounds are low.
#. Mode of Action:
H1 Antagonists act by competitively inhibiting the effects of Histamine at H1
receptor.

H1 receptor blockade results in decreased vascular permeability.

Reduction of pruritus, relaxation of smooth muscle in the respiratory.

GIT.
#. USES: 01. Allergic Reactions.
02. Block the release of histamine.
03. Not effective in humoral & cell mediated allergies.
❑. Question:05 Explain SAR of Ethylenediamine Derivatives?
❑. Question:06 Gives Uses & Mode of Action of H1 Antagonists?
The second-generation drugs have little affinity for muscarinic, adrenergic receptors.
The second-Generation have a relative low affinity for central H1 receptor & largely from sedation.
Examples: Terfenadine, Fexofenadine, cetirizine.
“Terfenadine” is a long acting H1 Antagonists.
“Fexofenadine” is a primary oxidation metabolite of “Terfenadine” & does not cross the BBB.
“Cetirizine” highly selective in its interaction with various neuronal binding sites & highly potent as well.
Ar
1 X C C N
Ar’ 3
In the above general structure, Ar is aryl group & Ar’ is aryl methyl group.
In the general structure the X part determines the class of drug to which that belongs i.e. if X = O (amino
alkyl analogue), X = N (Ethylene diamine derivatives).
Some times two aromatic rings are bridges that constitutes the tricycle ring derivatives.
❑. Question:08 Explain SAR of H1 Antagonists?
❑. Question:07 Write the note on Second generation H1 Antagonists?
Terfenadine Fexofenadine
Cetirizine
4
2
Most of the H1 Antagonists have ethylene chain, extension of this chain or branching of this chain leads
to reduce the activity of the compounds.
Homologation played to improve the drug like tricyclic anti-depressants, neuroleptics.
Due to the close resemblance of antihistamine structure to the cholinergic blocking agents, most of the
antihistamines show the activity of anti-cholinergic activity.
Diphenhydramine have maximum anti-cholinergic activity & maximum ability to cross the blood brain
barrier & are thus most effective in motion sickness.
#. Uses:
I. It is recommended in various allergic conditions & to a lesser as an antitussive & Parkinsonism
drugs.
II. It is also used OTC sleep air products.
III. Treatment of urticaria, seasonal rhinitis (hey fever) & some dermatoses.
❑. Question:09 Give Synthesis & Use of Diphenhydramine Chloride?
Promethazine hydrochloride is a white to faint yellow crystalline powder that Is very soluble in water, in
hot absolute alcohol, in chloroform.
#. USES:
I. Treating allergic illness such as hives, serum disease & hay fever.
II. Enhancing action of analgesics & local anesthetics.
III. Also, treatment of rheumatism with allergic components.
❑. Question:10 Give Synthesis & Use of Promethazine?
It is SP2 alkylamine.
It is available as an oral liquid or syrups & is administered every 6 hours.
#. USES:
I. It is used for allergy symptoms, rhinitis.
❑. Question:11 Give synthesis & uses of Triprolidine?
“Proton pump inhibitors (PPI) are a group of drugs whose main action is a pronounced & long-lasting
reduction of gastric acid production”.
GIT Problems, Gastritis, Dyspepsia, Peptic Ulcer disease (PUD) & Gastroesophageal reflux disease (GERD)
is the main uses of Proton Pump Inhibitors.
Gastritis Dyspepsia Peptic Ulcer GERD
Gastritis is an
inflammation, irritation
or erosion of the lining
of the stomach.
It can occur suddenly or
gradually.
Dyspepsia is an
uncomfortable feeling in
the upper middle part of
the stomach.
Peptic ulcer disease
refers to painful sores or
ulcers in the lining of
the stomach or first part
of the small intestine,
called the duodenum.
GERD is a digestive
disorder that affects the
lower esophageal
sphincter the ring of
muscle between the
esophagus & stomach.
Examples: Omeprazole, Lansoprazole, Esomeprazole, Pantoprazole & Rabeprazole etc.
Causes & Symptoms
PROTON PUMP INHIBITORS
❑. Question:01 Discuss about Proton Pump Inhibitors?
❑. Question:02 Draw the Chemical Structure of Proton Pump Inhibitors?
Omeprazole
Lansoprazole
Pantoprazole
Rabeprazole
Mechanism of blocking Na/K ATPase or Proton Pump
➢ Benzimidazole PPI’s are prodrug that are converted into sulfenamide within the acidic
environment of parietal cells in stomach.
➢ The consumption of food stimulates acid secretion and acid secretion activates PPIs.
➢ Then activated PPI is converted to a sulfenamide in the acidic secretory canaliculi of the parietal
cell.
➢ The sulfenamide interacts covalently with sulfhydryl groups (in cysteine amino acid of the
binding site) in the proton pump to create a disulphide bond between drug and pump and
thereby irreversibly inhibiting its activity.
• Irreversible covalent inhibitors are either substituted 2-
(pyridinemethylsulfinyl)benzimidazoles or a similar structure, pyridylmethyl sulfinyl
pyrido-imidazole, because they mainly inhibits the pump enzyme by covalently binding
to the α-subunit of the H+
,K+
-ATPase.
❑. Question:03 Explain the Mechanism of Action of Proton Pump Inhibitors?
❑. Question:04 Why Proton Pump Inhibitors are irreversible?
Mechanism of Acid Secretion: The H+
concentration in parietal cell secretions roughly 3 million-
fold higher than in blood, and Cl-
is secreted against both a concentration and electric gradient. The
parietal cell to secrete acid is dependent on active transport.
Acid secretion through "Proton Pump" located in the canalicular membrane. This ATPase is Mg+
dependent. The current model for explaining acid secretion in above.
• H+
are generated within parietal cell from dissociation of water. The H+
formed in this process
rapidly combine with CO2 to form HCO3
-
, a reaction catalyzed by carbonic anhydrase.
• HCO3
-
transport out from basolateral membrane in exchange for Cl-
. The outflow of bicarbonate
into blood results in a slight elevation of blood pH known as the "alkaline tide". This process
maintains intracellular pH in the parietal cell.
• Cl-
and K+
are transport into lumen of the canaliculus by conductance channels, necessary for
secretion of acid.
• H+
is pump out of cell, into the lumen, in exchange for K+
through the action of the proton pump;
K+
is thus effectively recycled.
• Accumulation of osmotically-active H+
generates an osmotic gradient across the membrane, the
resulting gastric juice is 155 mM HCl and 15 mM KCl with a small amount of NaCl.
❑. Question:05 Explain Secretion of Acid through the Proton Pump?
Neoplasm means: Tumour/Cancer.
Cancer is an uncontrolled proliferation express varying degree of fidelity to their precursors.
It can be “benign” or “Malignant”.
Benign: non-cancerous and not an immediate threat to life, even though treatment eventually may be
required for health.
Malignant: tending to worsen and cause death, invasive and metastasis.
01. Cancer involves the development and reproduction of abnormal cell.
02. Cancer cells are usually nonfunctional.
03. Cancer cell growth is not subject to normal body control mechanisms
04. Cancer cells eventually metastasize to other organs via the circulatory and lymphatic systems.
05. Metastasis.
Categorized based on the functions/locations as following:
1. Carcinoma - Skin or in tissues that line or cover internal organs. Ex: Epithelial cells, Glands. 80-
90% reported cancer cases are carcinomas.
2. Sarcoma - Bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue.
3. Leukemia - White blood cells and their precursor cells such as the bone marrow cells, causes
large numbers of abnormal blood cells to be produced and enter the blood.
4. Lymphoma - Cells of the immune system that affects lymphatic system.
5. Myeloma - Beta-cells that produce antibodies- spreads through lymphatic system.
6. Central Nervous System Cancers - Cancers that begin in the tissues of the brain and spinal
cord.
Characterstics
Antineoplastic Drugs
(Cancer)
❑. Question:01 Define Cancer with its Characteristics?
❑. Question:02 Classify Tumors on the basis of their functions/locations?
Antineoplastic agents are drugs used for the treatment of cancer.
• The fraction of tumor cells that are in the replicative cycle (“Growth factor”), influence their
susceptibility to most cancer chemotherapeutic agent.
Rapidly dividing cells are generally more sensitive to anticancer drugs, whereas non proliferating
cells [those in G0 phase] usually survive the toxic effect of these drugs.
• Normal cells and tumor cells go through growth cycle. However, normal and neoplastic tissue
may differ only in the number of cells that are in the various stages in the cycle.
Chemotherapeutic agents that are effective only in replicating cells.
01. Phase Specific Agents: These drugs act at particular phase of cell cycle and more effective in
proliferating cells.
❑ G1 – Vincristine
❑ S– Methotrexate, Cytarabine, 6-TG, 6-MP, 5-FU, Daunorubicin, Doxorubicin
❑ G2 – Daunorubicin, Bleomycin
❑ M – Vincristine, Vinblastne, Paclitaxel etc.
02. Phase Non-Specific Agents: Nitrogen Mustards, Cyclphosphamide, Chlorambucil, Carmustine,
Dacarbazine, Busulfan, L-Asparginase, Cisplatin, Procarbazine and Actinomycin D etc.
a) These drugs are specifically effective against proliferating cells but they are not phase specific:
Ex: Fluorouracil, cyclophosphamide, Dactinomycin.
❑. Question:03 Explain the Cell cycle & relation with cancer drugs?
❑. Question:04 Classify Anticancer Agents based on its site of Action?
A. Alkylating Agents
1. Nitrogen Mustards – Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan,
Chlorambucil.
2. Ethylenimine - Thio-Tepa, Hexamethyl melamine.
3. Alkyl Sulphonate – Busulphan.
4. Nitrosoureas – Carmustine, Lomustine, Streptozocin.
5. Triazines - Procarbazine, Dacarbazine, Temozolomide.
B. Platinum Coordination Complexes – Cisplatin, Carboplatin, Oxaliplatin.
C. Antimetabolites
I. Pyrimidine Analogs - 5-Fluorouracil, Cytarabine (cytosine arabinoside),
Capecitabine, Gemcitabine.
II.Purine Analogs – 6-Mercaptopurine, 6-Thioguanine, Azathioprine,
Fludarabine, Cladribine, Pentostatin.
II. Folic acid analogues – Methotrexate, Pemetrexed, Trimetrexate.
D. Anticancer Antibiotics – Actinomycin-D (Dactinomycin), Bleomycin, mitomycin- C, anthracyclines (e.g.
Doxorubicin, Daunorubicin, Idarubicin, epirubicin, Valrubicin), Streptozocin.
E. Plant Products- Vincristine, vinblastine, podophyllotoxin, etoposide, camptothecin, paclitaxel.
F. Protein Kinase Inhibitors- Imatinib, Dasatinib, Gefitinib, Erlotinib.
G. Miscellaneous – L-Asparaginase, Arsenic trioxide.
H. Hormonal Drugs –
1.Glucocorticoids – Prednisolon.
2. Estrogens – Fosfestrol, Ethinylestradiol.
3.Selective estrogen receptor modulator – Tamoxifen.
4.Selective estrogen receptor down regulator – Fulvestrant.
5. Aromatase Inhibitor – Anastrazole.
6. Antiandrogen – Flutamide, Bicalutamide.
7. 5 α Reductase Inhibitor – Finasteride.
8.GnRH Analog – Leuprorelin.
9. GnRH Antagonist – Cetorelix, Abarelix
10. Progestins – Hydroxyprogesterone acetate
❑. Question:05 Classify Anticancer Agents based on their chemical Structure?

More Related Content

What's hot

Rationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration ofRationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration of
College of Pharmacy,Sri Ramakrishna Institute of Paramedical Sciences,Coimbatore
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug design
Prof. Aejaz Ahmed Boraji
 
BIOISOSTERSM
BIOISOSTERSMBIOISOSTERSM
BIOISOSTERSM
Tuba Khan
 
organic reaction
organic reactionorganic reaction
organic reaction
NiketBajare
 
Traube purine synthesis
Traube purine synthesisTraube purine synthesis
Traube purine synthesis
Karanvir Rajput
 
Analog design bioisosterism
Analog design bioisosterismAnalog design bioisosterism
Analog design bioisosterism
Praba karan
 
ANTIBIOTICS[PENICILLINS] MEDICINAL CHEMISTRY BY RAVISANKAR
ANTIBIOTICS[PENICILLINS] MEDICINAL CHEMISTRY BY RAVISANKARANTIBIOTICS[PENICILLINS] MEDICINAL CHEMISTRY BY RAVISANKAR
ANTIBIOTICS[PENICILLINS] MEDICINAL CHEMISTRY BY RAVISANKAR
Dr. Ravi Sankar
 
Diuretics
Diuretics Diuretics
Diuretics
Akhil Nagar
 
QSAR
QSARQSAR
Rationale of prodrug design and practical considertions of prodrug design
Rationale of prodrug design and practical considertions of prodrug designRationale of prodrug design and practical considertions of prodrug design
Rationale of prodrug design and practical considertions of prodrug design
Keshari Sriwastawa
 
Pharmacophore modeling
Pharmacophore modelingPharmacophore modeling
Pharmacophore modeling
Devika Rana
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistry
Mohit umare
 
Chronopharmacology
Chronopharmacology Chronopharmacology
Chronopharmacology
Dr. Rupendra Bharti
 
1 st unit antibiotics
1 st unit antibiotics1 st unit antibiotics
1 st unit antibiotics
NikithaGopalpet
 
Cephalosporins b
Cephalosporins bCephalosporins b
Cephalosporins b
Prof. Aejaz Ahmed Boraji
 
Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2
Nirali Mistry
 
PROTON PUMP INHIBITORS
PROTON PUMP INHIBITORSPROTON PUMP INHIBITORS
PROTON PUMP INHIBITORS
Pharmacy Universe
 
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTSEnatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Shikha Popali
 
Medicinal chemistry of local anaesthetics
Medicinal chemistry of local anaestheticsMedicinal chemistry of local anaesthetics
Medicinal chemistry of local anaesthetics
suresh bairi
 
Global and local restrictions Peptidomimetics
Global and local restrictions Peptidomimetics Global and local restrictions Peptidomimetics
Global and local restrictions Peptidomimetics
ASHOK GAUTAM
 

What's hot (20)

Rationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration ofRationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration of
 
Basic concepts and application of prodrug design
Basic concepts and application of prodrug designBasic concepts and application of prodrug design
Basic concepts and application of prodrug design
 
BIOISOSTERSM
BIOISOSTERSMBIOISOSTERSM
BIOISOSTERSM
 
organic reaction
organic reactionorganic reaction
organic reaction
 
Traube purine synthesis
Traube purine synthesisTraube purine synthesis
Traube purine synthesis
 
Analog design bioisosterism
Analog design bioisosterismAnalog design bioisosterism
Analog design bioisosterism
 
ANTIBIOTICS[PENICILLINS] MEDICINAL CHEMISTRY BY RAVISANKAR
ANTIBIOTICS[PENICILLINS] MEDICINAL CHEMISTRY BY RAVISANKARANTIBIOTICS[PENICILLINS] MEDICINAL CHEMISTRY BY RAVISANKAR
ANTIBIOTICS[PENICILLINS] MEDICINAL CHEMISTRY BY RAVISANKAR
 
Diuretics
Diuretics Diuretics
Diuretics
 
QSAR
QSARQSAR
QSAR
 
Rationale of prodrug design and practical considertions of prodrug design
Rationale of prodrug design and practical considertions of prodrug designRationale of prodrug design and practical considertions of prodrug design
Rationale of prodrug design and practical considertions of prodrug design
 
Pharmacophore modeling
Pharmacophore modelingPharmacophore modeling
Pharmacophore modeling
 
Analog design medicinal chemistry
Analog design medicinal chemistryAnalog design medicinal chemistry
Analog design medicinal chemistry
 
Chronopharmacology
Chronopharmacology Chronopharmacology
Chronopharmacology
 
1 st unit antibiotics
1 st unit antibiotics1 st unit antibiotics
1 st unit antibiotics
 
Cephalosporins b
Cephalosporins bCephalosporins b
Cephalosporins b
 
Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2Synthesis Of Hetero-cyclic Drugs 2
Synthesis Of Hetero-cyclic Drugs 2
 
PROTON PUMP INHIBITORS
PROTON PUMP INHIBITORSPROTON PUMP INHIBITORS
PROTON PUMP INHIBITORS
 
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTSEnatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
Enatiopure separation and stereo selective synthesis FOR PHARMACY STUDENTS
 
Medicinal chemistry of local anaesthetics
Medicinal chemistry of local anaestheticsMedicinal chemistry of local anaesthetics
Medicinal chemistry of local anaesthetics
 
Global and local restrictions Peptidomimetics
Global and local restrictions Peptidomimetics Global and local restrictions Peptidomimetics
Global and local restrictions Peptidomimetics
 

Similar to MedChem Assignments Histamine, H1, Proton Pump & Cancer (Rahul Pals)

H1 & h2 receptor blockers
H1 &  h2 receptor blockersH1 &  h2 receptor blockers
H1 & h2 receptor blockers
arzoo dharasandiya
 
H1 & H2 receptor antagonist
H1 & H2 receptor antagonistH1 & H2 receptor antagonist
H1 & H2 receptor antagonist
Ashok Jangra
 
Advanced Medicinal Chemistry: H1&H2 antagonists
Advanced Medicinal Chemistry: H1&H2 antagonistsAdvanced Medicinal Chemistry: H1&H2 antagonists
Advanced Medicinal Chemistry: H1&H2 antagonists
Sapna Sivanthie
 
Antihistamines
AntihistaminesAntihistamines
Antihistamines
Raju Sanghvi
 
Anti histamine drug
Anti  histamine drug Anti  histamine drug
Anti histamine drug
AnamikaSingh427
 
Anti histamine
Anti  histamineAnti  histamine
Anti histamine
Anamikasingh405
 
Antihistaminc agents
Antihistaminc agentsAntihistaminc agents
Antihistaminc agents
Kratika Daniel
 
H1andh2receptors 170911151157 amit patidar
H1andh2receptors 170911151157 amit patidarH1andh2receptors 170911151157 amit patidar
H1andh2receptors 170911151157 amit patidar
Amit Patidar Patidar
 
H1and h2 receptors
H1and h2 receptorsH1and h2 receptors
H1and h2 receptors
Sanjay Gopi
 
H1 and H2.pptx
H1 and H2.pptxH1 and H2.pptx
H1 and H2.pptx
Sri Lakshmi
 
Antihistaminic Agents.pptx
Antihistaminic Agents.pptxAntihistaminic Agents.pptx
Antihistaminic Agents.pptx
Ajeet Singh Gangwar
 
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdfSYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
Professor Afzal Basha Shaik
 
Anti histamines-1.pptx
Anti histamines-1.pptxAnti histamines-1.pptx
Anti histamines-1.pptx
ABDULRAUF411
 
Anti histamines drugs
Anti histamines drugsAnti histamines drugs
Anti histamines drugs
Ravish Yadav
 
Antihistaminics-Medicinal Chemistry
Antihistaminics-Medicinal ChemistryAntihistaminics-Medicinal Chemistry
Antihistaminics-Medicinal Chemistry
Dr. Gopal Krishna Padhy
 
Histamin-Medicinal Chemistry MANIK
Histamin-Medicinal Chemistry MANIKHistamin-Medicinal Chemistry MANIK
Histamin-Medicinal Chemistry MANIK
Imran Nur Manik
 
adrenergic agents
adrenergic agentsadrenergic agents
adrenergic agents
Leeds Francisco
 
H1 and H2 antagonist Medicinal Chemistry.pptx
H1 and H2 antagonist Medicinal Chemistry.pptxH1 and H2 antagonist Medicinal Chemistry.pptx
H1 and H2 antagonist Medicinal Chemistry.pptx
AniketShrivastava14
 
Antihisminic agents
Antihisminic agentsAntihisminic agents
Antihisminic agents
SurendraKumar338
 
H1 and H2 Receptor Antagonist.pptx
H1 and H2 Receptor Antagonist.pptxH1 and H2 Receptor Antagonist.pptx
H1 and H2 Receptor Antagonist.pptx
Mayur Karanjekar
 

Similar to MedChem Assignments Histamine, H1, Proton Pump & Cancer (Rahul Pals) (20)

H1 & h2 receptor blockers
H1 &  h2 receptor blockersH1 &  h2 receptor blockers
H1 & h2 receptor blockers
 
H1 & H2 receptor antagonist
H1 & H2 receptor antagonistH1 & H2 receptor antagonist
H1 & H2 receptor antagonist
 
Advanced Medicinal Chemistry: H1&H2 antagonists
Advanced Medicinal Chemistry: H1&H2 antagonistsAdvanced Medicinal Chemistry: H1&H2 antagonists
Advanced Medicinal Chemistry: H1&H2 antagonists
 
Antihistamines
AntihistaminesAntihistamines
Antihistamines
 
Anti histamine drug
Anti  histamine drug Anti  histamine drug
Anti histamine drug
 
Anti histamine
Anti  histamineAnti  histamine
Anti histamine
 
Antihistaminc agents
Antihistaminc agentsAntihistaminc agents
Antihistaminc agents
 
H1andh2receptors 170911151157 amit patidar
H1andh2receptors 170911151157 amit patidarH1andh2receptors 170911151157 amit patidar
H1andh2receptors 170911151157 amit patidar
 
H1and h2 receptors
H1and h2 receptorsH1and h2 receptors
H1and h2 receptors
 
H1 and H2.pptx
H1 and H2.pptxH1 and H2.pptx
H1 and H2.pptx
 
Antihistaminic Agents.pptx
Antihistaminic Agents.pptxAntihistaminic Agents.pptx
Antihistaminic Agents.pptx
 
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdfSYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
SYMPATHOMIMETICS AND SYMPATHOLYTICS PCI SYLLABU.pdf
 
Anti histamines-1.pptx
Anti histamines-1.pptxAnti histamines-1.pptx
Anti histamines-1.pptx
 
Anti histamines drugs
Anti histamines drugsAnti histamines drugs
Anti histamines drugs
 
Antihistaminics-Medicinal Chemistry
Antihistaminics-Medicinal ChemistryAntihistaminics-Medicinal Chemistry
Antihistaminics-Medicinal Chemistry
 
Histamin-Medicinal Chemistry MANIK
Histamin-Medicinal Chemistry MANIKHistamin-Medicinal Chemistry MANIK
Histamin-Medicinal Chemistry MANIK
 
adrenergic agents
adrenergic agentsadrenergic agents
adrenergic agents
 
H1 and H2 antagonist Medicinal Chemistry.pptx
H1 and H2 antagonist Medicinal Chemistry.pptxH1 and H2 antagonist Medicinal Chemistry.pptx
H1 and H2 antagonist Medicinal Chemistry.pptx
 
Antihisminic agents
Antihisminic agentsAntihisminic agents
Antihisminic agents
 
H1 and H2 Receptor Antagonist.pptx
H1 and H2 Receptor Antagonist.pptxH1 and H2 Receptor Antagonist.pptx
H1 and H2 Receptor Antagonist.pptx
 

More from RAHUL PAL

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
RAHUL PAL
 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
RAHUL PAL
 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
RAHUL PAL
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
RAHUL PAL
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
RAHUL PAL
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
RAHUL PAL
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
RAHUL PAL
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
RAHUL PAL
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
RAHUL PAL
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
RAHUL PAL
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
RAHUL PAL
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
RAHUL PAL
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
RAHUL PAL
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
RAHUL PAL
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
RAHUL PAL
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
RAHUL PAL
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
RAHUL PAL
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
RAHUL PAL
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
RAHUL PAL
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
RAHUL PAL
 

More from RAHUL PAL (20)

Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdfSoftware Used In Formulation Design Process- Minor Project [Bachelor].pdf
Software Used In Formulation Design Process- Minor Project [Bachelor].pdf
 
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdfMajor Project (B. Pharm) OPIUM POPPY PROJECT.pdf
Major Project (B. Pharm) OPIUM POPPY PROJECT.pdf
 
Niosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdfNiosome Formulation And Evaluations .pdf
Niosome Formulation And Evaluations .pdf
 
Niosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptxNiosome An Non-Ionic Surfactant Vesicles.pptx
Niosome An Non-Ionic Surfactant Vesicles.pptx
 
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
𝐎𝐫𝐚𝐥 𝐏𝐚𝐩𝐞𝐫 𝐏𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧: 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐟𝐞𝐫𝐞𝐧𝐜𝐞 (𝐈𝐑𝐓𝐄𝐂 𝟐.𝟎-𝟐𝟎𝟐𝟒); The Curre...
 
Thakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdfThakur35352024JPRI111654.pdf
Thakur35352024JPRI111654.pdf
 
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
THE CURRENT STATUS IN MUCOSAL DRUG DELIVERY SYSTEM (MDDS) AND FUTURE PROSPECT...
 
Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...Design of Experiments (DoE) manipulation in the formulation and optimization ...
Design of Experiments (DoE) manipulation in the formulation and optimization ...
 
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...The Utilization of 32 Full Factorial  Design (FFD) for Optimization of  Linco...
The Utilization of 32 Full Factorial Design (FFD) for Optimization of Linco...
 
Determination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdfDetermination of Partition coefficient of Known and Unknown drug.pdf
Determination of Partition coefficient of Known and Unknown drug.pdf
 
Pharmaceutical Suspension.ppt
Pharmaceutical Suspension.pptPharmaceutical Suspension.ppt
Pharmaceutical Suspension.ppt
 
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.pptPHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
PHARMACEUTICAL SUPPOSITORIES & PESSARIES.ppt
 
Partition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptxPartition Coefficient Determination (Pharmaceutics Practical).pptx
Partition Coefficient Determination (Pharmaceutics Practical).pptx
 
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
Research Methodology_UNIT_V_Declaration of Helsinki M. Pharm (IIIrd Sem.)
 
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
The Utilization of Response Surface Methodology (RSM) In the Optimization of ...
 
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
Research Methodology (M. Pharm, IIIrd Sem.)_UNIT_IV_CPCSEA Guidelines for Lab...
 
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
MEDICAL RESEARCH: UNIT_III_ EUTHANASIA, COI, CONFIDENTIALITY RESEARCH METHODO...
 
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
Biostatistics_Unit_II_Research Methodology & Biostatistics_M. Pharm (Pharmace...
 
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
(I) MEDICAL RESEARCH_ UNIT_III_RESEARCH METHODOLOGY & BIOSTATISTICS.pptx
 
Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...Research Article Published: "Optimization and formulation of dox loaded lipos...
Research Article Published: "Optimization and formulation of dox loaded lipos...
 

Recently uploaded

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 

Recently uploaded (20)

Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 

MedChem Assignments Histamine, H1, Proton Pump & Cancer (Rahul Pals)

  • 1.  The chemical name of Histamine is “2-(4H-imidazol-5-yl) ethanamine (Histamine)”. Histamine synthesized in cytoplasmic granules of a its storage cells, mast cells & basophils. It is formed from naturally occurring amino acids, S-Histidine, via the catalysis of pyridoxal phosphate- dependent enzymes histidine decarboxylase/ aromatic decarboxylase. Histamine is a chiral molecule. HISTAMINE ❑. Question:01 Write the chemical name & structure of Histamine? ❑. Question:02 Explain biosynthesis of Histamine? NH2 N HN H H Histamine HDC COOH HN N HN N H NH2 NH2 H H S-Histidine Histidine Histidine Decarboxylase RAHUL PAL 5TH SEM B. PHARAM
  • 2. Drugs the block the action of histamine of H1, H2, H4 & H4 receptors. The development of Antihistamines Began by the discovery of “Piperoxam”. A. Drugs that inhibits the histamine release. B. Drugs that inhibits the action of released histamine. ❑ H1 Antagonists (I, II, III generation Antagonists) ❑ H2 Antagonists. ❑ H3 Antagonists. C. Drugs having dual action. H1 Antagonists (1st Generation) The amine is substituted with the small alkyl group. Classification: The commonly used antihistamines may be classified on the basis of their chemical structures: . Amino Alkyl Ethers: Diphenhydramine, Doxylamine, Clemastine, medrylamine, Carbinoxmine, Bromodiphenhydramine. . Ethylenediamine: Tripelenamine, pyrilamine, methapyrilene, thonzalamine, Zolamine. . Propyl Amine Derivatives: Saturated drugs: pheniramine, chlorpheramine, Unsaturated Drugs: Pyrrobutamine, triprolidine. . Phenothiazine Derivatives. Promethazine, Trimeprazine. . Piperazine Derivative. Cyclazine, chlorcyclines, meclizine. H1 Antagonists (2nd Generation) Laratidine, Estemizole. H1 Antagonists (3rd Generation) Acrivestine. H2 Antagonists Cemetidine, famotidine, ranitidine, nizatidine. H3 Antagonist Omeprazole, Lansoprazole, Rabeprazole, Pantoprazole. ❑. Question: 03 Classification of Antihistamines?
  • 3. Histamines receptors are belonging to the family of G-Protein Coupled receptors. These subtypes of histamine receptors: A. H1. B. H2. C. H3. D. H4. Receptors H1 H2 H3 H4 Locations Brain, GIT, CVS, Lymphocytes. Myocardial cells, parietal cells. CNS, Myentric plexus, gastric Mucosa. Spleen, thymus, T-cells, eosinophils. ❑. Question: 04 Name the different type of Histamine receptors & their Distribution?
  • 4. 01. Amino Alkyl Ether: Diphenhydramine, Bromodiphenhydramine, Dimenhydrinate, Doxylamine succinate, Diphenylpyraline. 02. Ethylenediamine: Mepyramine, Tripelennamine, Thonzylamine, Zolamine. 03. Thiophene Derivatives: Methapyrilene, Methaphenilene, Thenyldiamine, Chlorothen Citrate. 04. Cyclic Basic Chain Analogues: A. Imidazoline: Antazoline. B. Piperazine: Cyclizine, Chlorcyclizine, Meclizine, Buclizine. C. Piperidine: Thenalidine Tartarate. 05. Phenothiazine: Promethazine, Promethazine Teolclate, Trimeprazine, Methdilazine. 06. Second-Generation Non-Sedating Antihistamines: Terfenadine, Astemizole, Loratadine, Acrivastine. 07. Miscellaneous Agents: Phenindamine, Triprolidine, Chlorpheniramine, Cyproheptadine. Sedative antihistamines: N-Dimethylthenamine.HCl & 1-Methyl Piperidine. Non-Sedative Antihistamine: Fexofenadine, Citrizine Levocetrazine, loratadine, Desloratadine, Acrivastine. Ar is Aryl: Phenyl, substituted phenyl, heteroaryl groups such as 2-pyridyl. Ar1: Second aryl or aryl methyl group. (CH2) n: Represents a carbon chain, usually ethyl. NRR1 = Basic, terminal amine functional group. X = Connecting atom of 0, C & N. ❑. Question:01 Give the classification of H1 Antagonists? ❑. Question:02 Explain SAR of Amino Alkyl Ethers? H1 ANTAGONISTS R R1
  • 5. Mepyramine, Tripelennamine, Thonzylamine, Zolamine. ❑. Question:03 Give Chemical Structure of Amino Alkyl Ethers? ❑. Question:04 Give Chemical Structure of Ethylenediamine Derivatives? Mepyramine Tripelennamine Thonzylamine Zolamine
  • 6. ANS: Structure Activity Relationship: ➢ Ethylenediamine derivatives are characterized by “Nitrogen” connecting atom. ➢ Phenbenzamine was first clinically useful member. ➢ Replacement of phenyl moiety of Phenbezamine with a 2-pyridyl system yielded “tripelennamine”. ➢ Replacements of benzyl group of tripelennamine with a 2-thienulmethyl group provided methapyrilene. ➢ Replacement of tripelennamine with 2pyridyl group with a pyrimidinyl moiety yields thonzylamine. ➢ The anticholinergic & antiemetics action of these compounds are low. #. Mode of Action: H1 Antagonists act by competitively inhibiting the effects of Histamine at H1 receptor.  H1 receptor blockade results in decreased vascular permeability.  Reduction of pruritus, relaxation of smooth muscle in the respiratory.  GIT. #. USES: 01. Allergic Reactions. 02. Block the release of histamine. 03. Not effective in humoral & cell mediated allergies. ❑. Question:05 Explain SAR of Ethylenediamine Derivatives? ❑. Question:06 Gives Uses & Mode of Action of H1 Antagonists?
  • 7. The second-generation drugs have little affinity for muscarinic, adrenergic receptors. The second-Generation have a relative low affinity for central H1 receptor & largely from sedation. Examples: Terfenadine, Fexofenadine, cetirizine. “Terfenadine” is a long acting H1 Antagonists. “Fexofenadine” is a primary oxidation metabolite of “Terfenadine” & does not cross the BBB. “Cetirizine” highly selective in its interaction with various neuronal binding sites & highly potent as well. Ar 1 X C C N Ar’ 3 In the above general structure, Ar is aryl group & Ar’ is aryl methyl group. In the general structure the X part determines the class of drug to which that belongs i.e. if X = O (amino alkyl analogue), X = N (Ethylene diamine derivatives). Some times two aromatic rings are bridges that constitutes the tricycle ring derivatives. ❑. Question:08 Explain SAR of H1 Antagonists? ❑. Question:07 Write the note on Second generation H1 Antagonists? Terfenadine Fexofenadine Cetirizine 4 2
  • 8. Most of the H1 Antagonists have ethylene chain, extension of this chain or branching of this chain leads to reduce the activity of the compounds. Homologation played to improve the drug like tricyclic anti-depressants, neuroleptics. Due to the close resemblance of antihistamine structure to the cholinergic blocking agents, most of the antihistamines show the activity of anti-cholinergic activity. Diphenhydramine have maximum anti-cholinergic activity & maximum ability to cross the blood brain barrier & are thus most effective in motion sickness. #. Uses: I. It is recommended in various allergic conditions & to a lesser as an antitussive & Parkinsonism drugs. II. It is also used OTC sleep air products. III. Treatment of urticaria, seasonal rhinitis (hey fever) & some dermatoses. ❑. Question:09 Give Synthesis & Use of Diphenhydramine Chloride?
  • 9. Promethazine hydrochloride is a white to faint yellow crystalline powder that Is very soluble in water, in hot absolute alcohol, in chloroform. #. USES: I. Treating allergic illness such as hives, serum disease & hay fever. II. Enhancing action of analgesics & local anesthetics. III. Also, treatment of rheumatism with allergic components. ❑. Question:10 Give Synthesis & Use of Promethazine?
  • 10. It is SP2 alkylamine. It is available as an oral liquid or syrups & is administered every 6 hours. #. USES: I. It is used for allergy symptoms, rhinitis. ❑. Question:11 Give synthesis & uses of Triprolidine?
  • 11. “Proton pump inhibitors (PPI) are a group of drugs whose main action is a pronounced & long-lasting reduction of gastric acid production”. GIT Problems, Gastritis, Dyspepsia, Peptic Ulcer disease (PUD) & Gastroesophageal reflux disease (GERD) is the main uses of Proton Pump Inhibitors. Gastritis Dyspepsia Peptic Ulcer GERD Gastritis is an inflammation, irritation or erosion of the lining of the stomach. It can occur suddenly or gradually. Dyspepsia is an uncomfortable feeling in the upper middle part of the stomach. Peptic ulcer disease refers to painful sores or ulcers in the lining of the stomach or first part of the small intestine, called the duodenum. GERD is a digestive disorder that affects the lower esophageal sphincter the ring of muscle between the esophagus & stomach. Examples: Omeprazole, Lansoprazole, Esomeprazole, Pantoprazole & Rabeprazole etc. Causes & Symptoms PROTON PUMP INHIBITORS ❑. Question:01 Discuss about Proton Pump Inhibitors? ❑. Question:02 Draw the Chemical Structure of Proton Pump Inhibitors? Omeprazole Lansoprazole Pantoprazole Rabeprazole
  • 12. Mechanism of blocking Na/K ATPase or Proton Pump ➢ Benzimidazole PPI’s are prodrug that are converted into sulfenamide within the acidic environment of parietal cells in stomach. ➢ The consumption of food stimulates acid secretion and acid secretion activates PPIs. ➢ Then activated PPI is converted to a sulfenamide in the acidic secretory canaliculi of the parietal cell. ➢ The sulfenamide interacts covalently with sulfhydryl groups (in cysteine amino acid of the binding site) in the proton pump to create a disulphide bond between drug and pump and thereby irreversibly inhibiting its activity. • Irreversible covalent inhibitors are either substituted 2- (pyridinemethylsulfinyl)benzimidazoles or a similar structure, pyridylmethyl sulfinyl pyrido-imidazole, because they mainly inhibits the pump enzyme by covalently binding to the α-subunit of the H+ ,K+ -ATPase. ❑. Question:03 Explain the Mechanism of Action of Proton Pump Inhibitors? ❑. Question:04 Why Proton Pump Inhibitors are irreversible?
  • 13. Mechanism of Acid Secretion: The H+ concentration in parietal cell secretions roughly 3 million- fold higher than in blood, and Cl- is secreted against both a concentration and electric gradient. The parietal cell to secrete acid is dependent on active transport. Acid secretion through "Proton Pump" located in the canalicular membrane. This ATPase is Mg+ dependent. The current model for explaining acid secretion in above. • H+ are generated within parietal cell from dissociation of water. The H+ formed in this process rapidly combine with CO2 to form HCO3 - , a reaction catalyzed by carbonic anhydrase. • HCO3 - transport out from basolateral membrane in exchange for Cl- . The outflow of bicarbonate into blood results in a slight elevation of blood pH known as the "alkaline tide". This process maintains intracellular pH in the parietal cell. • Cl- and K+ are transport into lumen of the canaliculus by conductance channels, necessary for secretion of acid. • H+ is pump out of cell, into the lumen, in exchange for K+ through the action of the proton pump; K+ is thus effectively recycled. • Accumulation of osmotically-active H+ generates an osmotic gradient across the membrane, the resulting gastric juice is 155 mM HCl and 15 mM KCl with a small amount of NaCl. ❑. Question:05 Explain Secretion of Acid through the Proton Pump?
  • 14. Neoplasm means: Tumour/Cancer. Cancer is an uncontrolled proliferation express varying degree of fidelity to their precursors. It can be “benign” or “Malignant”. Benign: non-cancerous and not an immediate threat to life, even though treatment eventually may be required for health. Malignant: tending to worsen and cause death, invasive and metastasis. 01. Cancer involves the development and reproduction of abnormal cell. 02. Cancer cells are usually nonfunctional. 03. Cancer cell growth is not subject to normal body control mechanisms 04. Cancer cells eventually metastasize to other organs via the circulatory and lymphatic systems. 05. Metastasis. Categorized based on the functions/locations as following: 1. Carcinoma - Skin or in tissues that line or cover internal organs. Ex: Epithelial cells, Glands. 80- 90% reported cancer cases are carcinomas. 2. Sarcoma - Bone, cartilage, fat, muscle, blood vessels, or other connective or supportive tissue. 3. Leukemia - White blood cells and their precursor cells such as the bone marrow cells, causes large numbers of abnormal blood cells to be produced and enter the blood. 4. Lymphoma - Cells of the immune system that affects lymphatic system. 5. Myeloma - Beta-cells that produce antibodies- spreads through lymphatic system. 6. Central Nervous System Cancers - Cancers that begin in the tissues of the brain and spinal cord. Characterstics Antineoplastic Drugs (Cancer) ❑. Question:01 Define Cancer with its Characteristics? ❑. Question:02 Classify Tumors on the basis of their functions/locations?
  • 15. Antineoplastic agents are drugs used for the treatment of cancer. • The fraction of tumor cells that are in the replicative cycle (“Growth factor”), influence their susceptibility to most cancer chemotherapeutic agent. Rapidly dividing cells are generally more sensitive to anticancer drugs, whereas non proliferating cells [those in G0 phase] usually survive the toxic effect of these drugs. • Normal cells and tumor cells go through growth cycle. However, normal and neoplastic tissue may differ only in the number of cells that are in the various stages in the cycle. Chemotherapeutic agents that are effective only in replicating cells. 01. Phase Specific Agents: These drugs act at particular phase of cell cycle and more effective in proliferating cells. ❑ G1 – Vincristine ❑ S– Methotrexate, Cytarabine, 6-TG, 6-MP, 5-FU, Daunorubicin, Doxorubicin ❑ G2 – Daunorubicin, Bleomycin ❑ M – Vincristine, Vinblastne, Paclitaxel etc. 02. Phase Non-Specific Agents: Nitrogen Mustards, Cyclphosphamide, Chlorambucil, Carmustine, Dacarbazine, Busulfan, L-Asparginase, Cisplatin, Procarbazine and Actinomycin D etc. a) These drugs are specifically effective against proliferating cells but they are not phase specific: Ex: Fluorouracil, cyclophosphamide, Dactinomycin. ❑. Question:03 Explain the Cell cycle & relation with cancer drugs? ❑. Question:04 Classify Anticancer Agents based on its site of Action?
  • 16. A. Alkylating Agents 1. Nitrogen Mustards – Mechlorethamine, Cyclophosphamide, Ifosfamide, Melphalan, Chlorambucil. 2. Ethylenimine - Thio-Tepa, Hexamethyl melamine. 3. Alkyl Sulphonate – Busulphan. 4. Nitrosoureas – Carmustine, Lomustine, Streptozocin. 5. Triazines - Procarbazine, Dacarbazine, Temozolomide. B. Platinum Coordination Complexes – Cisplatin, Carboplatin, Oxaliplatin. C. Antimetabolites I. Pyrimidine Analogs - 5-Fluorouracil, Cytarabine (cytosine arabinoside), Capecitabine, Gemcitabine. II.Purine Analogs – 6-Mercaptopurine, 6-Thioguanine, Azathioprine, Fludarabine, Cladribine, Pentostatin. II. Folic acid analogues – Methotrexate, Pemetrexed, Trimetrexate. D. Anticancer Antibiotics – Actinomycin-D (Dactinomycin), Bleomycin, mitomycin- C, anthracyclines (e.g. Doxorubicin, Daunorubicin, Idarubicin, epirubicin, Valrubicin), Streptozocin. E. Plant Products- Vincristine, vinblastine, podophyllotoxin, etoposide, camptothecin, paclitaxel. F. Protein Kinase Inhibitors- Imatinib, Dasatinib, Gefitinib, Erlotinib. G. Miscellaneous – L-Asparaginase, Arsenic trioxide. H. Hormonal Drugs – 1.Glucocorticoids – Prednisolon. 2. Estrogens – Fosfestrol, Ethinylestradiol. 3.Selective estrogen receptor modulator – Tamoxifen. 4.Selective estrogen receptor down regulator – Fulvestrant. 5. Aromatase Inhibitor – Anastrazole. 6. Antiandrogen – Flutamide, Bicalutamide. 7. 5 α Reductase Inhibitor – Finasteride. 8.GnRH Analog – Leuprorelin. 9. GnRH Antagonist – Cetorelix, Abarelix 10. Progestins – Hydroxyprogesterone acetate ❑. Question:05 Classify Anticancer Agents based on their chemical Structure?